🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
This study was conducted to determine the efficacy and safety of GWP42003 c...
Status
Completed
Location
Multiple Locations
Start Date
2012-05-09
Trial ID
NCT01562314
This study involves 2 parts, Part A and Part B. The purpose of Part A is to...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-09
Trial ID
NCT01681186
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
This first-in-human clinical trial with a randomized, double-blind, placebo...
Status
Completed
Location
Parexel Los Angeles Early Phase Clinical Unit
Start Date
2023-12-21
Trial ID
NCT06225115
The primary purpose of this study is to assess the safety and tolerability ...
Status
Completed
Location
ICON 1255 East 3900 South
Start Date
2024-02-20
Trial ID
NCT06286033
TLL018 is developed for treatment of autoimmune and inflammatory diseases i...
Status
Completed
Location
Frontage Clinical Services, Inc.
Start Date
2020-01-26
Trial ID
NCT04243083
Treatments Being Tested
This is a Phase I, single-center trial to assess the safety, tolerability, ...
Status
Recruiting
Location
Huashan Hospital, Fudan University
Start Date
2026-02-05
Trial ID
NCT07409922
Treatments Being Tested
The study will evaluate the hypothesis that at doses and plasma concentrati...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-04
Trial ID
NCT01098877